Cassava Sciences News

10-Q: Q3 2024 Earnings Report

Nov 7 16:34 ET

8-K: Q3 2024 Financial and Operating Results

Nov 7 08:13 ET

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Remi Barbier(4.2%)

Nov 4 16:16 ET

8-K: An Open Letter from President and CEO Rick Barry to the Cassava Community

Oct 8 08:16 ET

4: Statement of changes in beneficial ownership of securities-Officer Barry Richard

Oct 1 16:41 ET

8-K/A: Executive Employment Agreement (Amendment)

Oct 1 16:11 ET

8-K: Cassava Sciences Resolves SEC Investigation

Sep 27 07:39 ET

8-K: Consulting Agreement

Sep 17 16:25 ET

4: Statement of changes in beneficial ownership of securities-Officer Schoen Eric

Sep 9 17:51 ET

4: Statement of changes in beneficial ownership of securities-Officer Cook Robert Christopher

Sep 9 17:46 ET

4: Statement of changes in beneficial ownership of securities-Officer Kupiec James William

Sep 9 17:46 ET

8-K: Cassava Sciences Names Rick Barry as Chief Executive Officer; Claude Nicaise, M.D. appointed Chairman of the Board

Sep 9 08:50 ET

SCHEDULE 13G: Others

Aug 21 12:50 ET

8-K/A: Cassava Sciences Reports Q2 2024 Financial Results and Operational Updates (Amendment)

Aug 9 08:27 ET

10-Q: Q2 2024 Earnings Report

Aug 8 17:15 ET

8-K: Cassava Sciences Reports Q2 2024 Financial Results and Operational Updates

Aug 8 08:14 ET

8-K: An Open Letter to the Cassava Community from Rick Barry

Jul 22 08:17 ET

8-K: Notice of Pendency of Settlement

Jul 18 08:16 ET

8-K: Cassava Sciences Announces Changes in Executive Leadership, Enhanced Corporate Governance and Other Initiatives

Jul 17 09:16 ET

8-K: Cassava Sciences' Update on the Investigation of Dr Huaren Wang

Jul 1 08:03 ET